Medical Mycology

Papers
(The H4-Index of Medical Mycology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation33
Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification29
Ebselen and diphenyl diselenide against fungal pathogens: A systematic review27
Filamentous growth is a general feature of Candida auris clinical isolates27
COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City25
Emerging and future strategies in the management of recalcitrant Candida auris24
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients24
Clinical characteristics and risk factors for COVID-19-associated Candidemia22
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan21
Aspergillosis: Emerging risk groups in critically ill patients21
A review of recent research on antifungal agents against dermatophyte biofilms20
A comparison of presentations and outcomes of histoplasmosis across patients with varying immune status20
Cross-reactivity of a Histoplasma capsulatum antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa18
Farnesol: An approach on biofilms and nanotechnology18
Whole genome sequencing confirms Candida albicans and Candida parapsilosis microsatellite sporadic and persistent clones causing outbreaks of candidemia in neonates18
Opportunistic yeast pathogenCandidaspp.: Secreted and membrane-bound virulence factors18
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections17
Conventional therapy and new antifungal drugs againstMalasseziainfections17
Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles17
0.11396098136902